Followers | 840 |
Posts | 121790 |
Boards Moderated | 9 |
Alias Born | 09/05/2002 |

Tuesday, August 20, 2019 8:58:56 AM
https://finance.yahoo.com/news/1-elanco-buy-bayers-animal-101029292.html
Elanco Animal Health Incorporated (ELAN) today announced it has entered into an agreement with Bayer AG to acquire its animal health business in a transaction valued at US$7.6 billion. The transaction, which is subject to regulatory approval and other customary closing conditions, creates the second largest animal health leader [behind ZTS]…
The transaction will double Elanco’s Companion Animal business, advancing the company’s intentional portfolio mix transformation and creating a balance between its Food Animal and Companion Animal segments. Elanco expects the combined organization to continue to deliver mid-single digit revenue growth…
...Elanco will finance the transaction through both cash and equity. Bayer AG will receive $5.32 billion in cash…and $2.28 billion or approximately 68 million Elanco Animal Health common shares. This represents a 70 percent to 30 percent cash-to-equity mix.
Stock received by Bayer is subject to a 7.5 percent symmetrical collar centered on Elanco’s volume-weighted average price for the 30 trading days ended August 6, 2019 of $33.60.
The transaction is expected to close in mid-2020, subject to regulatory approvals and other customary closing conditions.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ELAN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2025 08:13:30 PM
- Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement • PR Newswire (US) • 07/10/2025 12:00:00 PM
- Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection • PR Newswire (US) • 07/09/2025 12:27:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2025 10:36:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/26/2025 08:01:32 PM
- Elanco Releases 2024 Impact Report and Introduces New Framework • PR Newswire (US) • 06/26/2025 05:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2025 08:49:00 PM
- Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) • PR Newswire (US) • 06/12/2025 08:17:00 PM
- Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief • PR Newswire (US) • 06/05/2025 11:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2025 09:32:53 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/30/2025 02:00:37 PM
- Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer • PR Newswire (US) • 05/28/2025 11:25:00 AM
- Elanco to Participate in the Upcoming Investor Conferences • PR Newswire (US) • 05/16/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2025 01:05:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2025 10:30:46 AM
- Elanco Animal Health Reports First Quarter 2025 Results • PR Newswire (US) • 05/07/2025 10:27:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2025 08:04:57 PM
- Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown • PR Newswire (US) • 05/05/2025 10:27:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/22/2025 08:08:56 PM
- Elanco's Breakthrough Treatment for Deadly Canine Parvovirus Has Saved Thousands of Puppies, Reaffirms Commitment to Increasing the Availability of Canine Parvovirus Monoclonal Antibody for Second Annual National Parvo Awareness Day • PR Newswire (US) • 04/22/2025 12:27:00 PM
- Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement • PR Newswire (US) • 04/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2025 09:58:45 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/27/2025 04:30:40 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/27/2025 04:21:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2025 11:12:18 PM
A New Mining Model Built for Speed, Scale and Profit • AGI • Jul 17, 2025 9:00 AM
Rainmaker Announces Successful Deployment of Another Fully Containerized Seawater to Tap System in Turks and Caicos • RAKR • Jul 17, 2025 8:40 AM
Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies • FITY • Jul 17, 2025 8:30 AM
A New Mining Model Is Emerging - And Wall Street Is Paying Attention • B • Jul 15, 2025 9:00 AM
Sanwire Files Complaint Against Intercept Music and Trillium Partners • SNWR • Jul 15, 2025 9:00 AM
Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices • BLO • Jul 15, 2025 8:47 AM